Articles
- Statistics: Research Focus Is Put on Recombinant Proteins
- Revealing the Secret of Our Bacteria Expression Systems (E. coli / Bacillus)
- Big Shuffle in Pharmaceutical Industry: New Round of GMP Certification Creates Chance for Company Acquisition
- Creative BioMart Releases a Bunch of New Recombinant Human MET Mutants
- Drug Company Concern: Trend in Pharmaceutical Information
- Drug Resistance Antibodies Speed Up Cancer Researches
- 2013 Year in Review: Creative BioMart’s Scientific Expertise in Recombinant Protein Production
- Christmas Presentation for Customers from Creative BioMart
- Worldwide Biotech/Biopharma Alliance (Dec. 20 – Dec. 19)
- New Study Revealed the Crystal Structure of Protein TET2
- EU Regulatory: Giant Pharmaceuticals Are Fined Again for Disorganizing Market
- Scientists Identified the Role of Osteopontin for Mesenchymal Stem Cells
- A Novel Biomarker for Metabolic Dysfunction and New Hope for Obesity—Protein PAR2
- Creative BioMart “Morning Talk”: Give Answers to Diagnostic Enzymes
- Hybridoma Offers a Powerful Solution for Monoclonal Antibodies
- Broader Portfolio of Recombinant Antibodies Launched by Creative BioMart
- Does Immune Response Depend on the Solar Cycle?
- Creative BioMart Updates New Product—Thrombin
- Learn More about Protein Structure Evolution with “Ancient” Proteins
- Retrospective Viewpoint: Biotechnology Companies Keep Going with Mergers
- Biomolecular Finding: New Toxic-antitoxic System May Help to Inspire New Antibiotics
- Worldwide BiotechBiopharma Alliance within the Two Days
- A Potential Way to Measure Injury with the Help of Protein Xin
- Opinion: A Summary of Antibody-drug Conjugates